NY Transcatheter Valves

Thursday, December 10, 2020, 8:00 AM - 1:30 PM EST, Online


Structural heart disease refers to a defect in the heart’s valves, walls, or chambers. The most common types of structural heart disease are aortic valve disease, mitral valve disease, tricuspid and pulmonic valve disease, hypertrophic cardiomyopathy and congenital heart disease, such as atrial septal defect and ventricular septal defect. This New York Transcatheter Valves course is poised to help healthcare professionals stay current on new and emerging approaches in the diagnosis, management and treatment of valvular and structural heart disease. A robust agenda combines individual and collective opinions from field expert clinicians and scholars. The educational format will consist of live transcatheter procedures with moderated discussions.

1. Appraise new and upcoming technologies in the management of structural heart disease to determine their benefit for patients.
2. Present indications, techniques, outcomes, and complications for transcatheter valve intervention in patients with native valve disease and bioprostectic valve dysfunction.
3. Evaluate the rationale, challenges, and necessity of the heart team approach to valvular heart disease, and the functionality of the team within a center of excellence.
4. Assess the barriers to care in patients with valvular heart disease with specific attention to current gaps in the timely delivery of percutaneous and surgical interventions.

This course will be complimentary, but if you would like your CME certificate that will come at a cost of $25.

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (5.25 hours), Non-Physician Attendance (5.25 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Thursday, December 10, 2020